Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1425)
  3. Review (81)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3379)
  2. Solid Tumor Oncology Division (3379)
  3. GSK Faculty (1068)
  4. Department of Pathology and Laboratory Medicine (806)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (659)
  6. Human Oncology and Pathogenesis Program (633)

More Groups

People
  1. Mark Kris (870)
  2. Alexander Drilon (634)
  3. Gregory Riely (602)
  4. Charles Rudin (493)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (99)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (701)
  2. Journal of Thoracic Oncology (514)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (157)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (780)
  2. Elsevier Inc. (735)
  3. American Association for Cancer Research (385)
  4. Oxford University Press (351)
  5. Nature Publishing Group (154)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Proton craniospinal irradiation for patients with solid tumor leptomeningeal metastasis- Final analysis of a phase II study
    Meeting Abstract

    Yang, J. T.; Yerramilli, D.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Baser, R. E.; Betof Warner, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response (HAMMER) in non-small cell lung cancer
    Meeting Abstract

    McMillan, M. T.; Gomez, D. R.; Reyngold, M.; Hajj, C.; O'Brien, D. A. R.; Crane, C. H.; Gönen, M.; Bott, M.; Schoenfeld, A. J.; Romesser, P. B.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • The impact of the time of day of radiotherapy and systemic therapy on disease control in locally advanced non -small cell lung cancer treated with chemoradiation and durvalumab
    Meeting Abstract

    McMillan, M. T.; Shepherd, A. F.; Cooper, A. J.; Schoenfeld, A. J.; Wu, A. J.; Simone, C. B. 2nd; Iyengar, P.; Gelblum, D.; Chaft, J.; Gomez, D. R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Results from CA240-0007, a phase 1/2 multiple expansion cohort study of BMS-986504 in patients (pts) with advanced solid tumors with homozygous MTAP deletion (MTAP-del)
    Meeting Abstract

    Rodon, J.; Jänne, P. A.; Leventakos, K.; George, B.; Henry, J. T.; Johnson, M. L.; Papadopoulos, K. P.; Batista, A. I.; Spira, C. P.; Zhao, Y.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Preliminary safety, pharmacokinetics, and antitumor activity of RMC-9805, an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma (PDAC) from a phase 1 study in advanced solid tumors
    Meeting Abstract

    Hong, D. S.; Papadopoulos, K.; Kim, D. W.; Parikh, A.; Barve, M.; Powderly, J.; Starodub, A.; Strickler, J.; Li, B. T.; Oberstein, P.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • First-in-human, phase 1 study of a selective RET inhibitor, LOXO-260, in patients with RET inhibitor refractory, RET-altered cancers
    Meeting Abstract

    Subbiah, V.; Drilon, A.; Bestvina, C.; Garon, E. B.; Wirth, L.; Worden, F.; Piha-Paul, S.; Rotow, J.; Johnson, M.; Kang, H.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQoL) with tepotinib in patients with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC) with brain, liver, adrenal or bone metastases in the phase II VISION trial
    Meeting Abstract

    Gasking, S.; Reinmuth, N.; Mazieres, J.; Popat, S.; Paz-Ares, L.; Hook, E.; Hatswell, A.; Vlassak, S.; Johne, A.; Vioix, H.; more...
    Asia-Pacific Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib by RET fusion partner in RET+ NSCLC: Results from the LIBRETTO-001 and LIBRETTO-431 trials
    Meeting Abstract

    Solomon, B.; Drilon, A.; Park, K.; Novello, S.; Nadal, E.; Besse, B.; Peled, N.; Peterson, P.; Barker, S.; Szpurka, A. M.; more...
    Asia-Pacific Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Updated tumor agnostic efficacy of selpercatinib in patients with RET fusion-positive solid tumors: LIBRETTO-001
    Meeting Abstract

    Ohe, Y.; Subbiah, V.; Sukrithan, V.; Robinson, B.; Deschler-Baier, B.; Iwasa, T.; Ohashi, K.; Goto, K.; Nishio, M.; Satouchi, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II study of defactinib (VS6063) in patients with tumors with NF2 Loss: Results from the NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocol U
    Journal Article

    Zauderer, M. G.; Jegede, O.; Jackman, D. M.; Zwiebel, J. A.; Gray, R. J.; Wang, V.; McShane, L. M.; Rubinstein, L. V.; Patton, D. R.; Williams, P. M.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save